Ensysce Biosciences

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell ENSC and other ETFs, options, and stocks.

About ENSC

Ensysce Biosciences, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of solutions for severe pain relief while reducing the fear of and the potential for misuse and overdose. The firm's Trypsin Activated Abuse Protection and Multi-Pill Abuse Resistance platforms are in the process of developing a new class of powerful, tamper-proof opioids that prevent both drug abuse and overdoses. 

CEO
D. Lynn Kirkpatrick
CEOD. Lynn Kirkpatrick
Employees
Employees
Headquarters
La Jolla, California
HeadquartersLa Jolla, California
Founded
2003
Founded2003
Employees
Employees

ENSC Key Statistics

Market cap
1.76M
Market cap1.76M
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
105.04K
Average volume105.04K
High today
$0.568
High today$0.568
Low today
$0.541
Low today$0.541
Open price
$0.55
Open price$0.55
Volume
43.80K
Volume43.80K
52 Week high
$7.20
52 Week high$7.20
52 Week low
$0.53
52 Week low$0.53
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.